4.6 Editorial Material

Measuring Benefit and Balancing Risk: Strategies for the Benefit-Risk Assessment of New Medicines in a Risk-Averse Environment

Related references

Note: Only part of the references are listed.
Article Public, Environmental & Occupational Health

A quantitative approach to benefit-risk assessment of medicines-part 1: The development of a new model using multi-criteria decision analysis

Filip Mussen et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)